national analysts conducted primary research with rheumatologists -- specifically , two panel discussions , 25 in-depth telephone interviews , and a mail survey of conference ( auranofin symposium and workshop ) participants -- to examine current treatment practices and to probe the rationale and motivations underlying treatment strategies in rheumatoid arthritis .
C0004320
auranofin
C0003873
rheumatoid arthritis